DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	EVPLL; FOXN1; TGM5; KRT34; SCEL; GJB5; KRT14; KRT5; DSP; SPRR1B; SPRR2E; SPRR2D; CRABP2; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KLK7; EMP1; ELF3; FABP5; BNC1; KRT32; KRT31; CST6; ZNF750; CERS3; ACER1; GRHL3; EVPL; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	42	82	51.219512195122	0	0	0	0	0	0	0
down	CLDN5; DSG1; TJP1; CDH19; CDH8; PKP3; PKP1; CDH17;	GO:0007043~cell-cell junction assembly	8	43	18.6046511627907	0.00012881037505008	0.00565513327129593	0.398024058904751	0.407169595533307	0.338172058592881	0.398024058904751	0.0488378301590973
down	TCF21; ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.00014557735307019	0.00621851368993077	0.449542866280753	0.460170013054877	0.363808926059721	0.449542866280753	0.0537031933398211
down	GABRB2; GABRA4; GABRG1; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	5	13	38.4615384615385	0.00014803279909836	0.00623908903933235	0.456977250816647	0.467931677949926	0.367565440161236	0.456977250816647	0.0538808824182799
down	CYP1A1; GLI2; BMP2; CCNB1; FOXF1; KLF5; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	8	45	17.7777777777778	0.0001700603190744	0.0069813073843402	0.524636084344541	0.537560668594196	0.399981870463002	0.524636084344541	0.0602906930691531
down	DEFB4A; CXCL10; SAA1; SAA2; MIF; NTF3; CX3CL1; GPNMB;	GO:0050918~positive chemotaxis	8	46	17.3913043478261	0.00019443079015424	0.00755362798734648	0.599235695255377	0.614595727677562	0.428719892290106	0.599235695255377	0.0652332638389782
down	SAA1; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	5	14	35.7142857142857	0.00019594985604631	0.00755362798734648	0.603721506478706	0.619397494962411	0.430410401129399	0.603525556622659	0.0652332638389782
down	UGT1A9; UGT1A6; UGT1A1; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	5	14	35.7142857142857	0.00019594985604631	0.00755362798734648	0.603721506478706	0.619397494962411	0.430410401129399	0.603525556622659	0.0652332638389782
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.00022332957795623	0.00840410471332919	0.687408440949284	0.705944795919652	0.460358834876345	0.687408440949284	0.0725779957675133
down	CLDN4; CLDN1; ANXA1; ADRA2A; OCLN; DUOX2;	GO:0090303~positive regulation of wound healing	6	24	25	0.00022882591535611	0.00850963198165495	0.704097341550758	0.723318718440671	0.466347215495757	0.704097341550758	0.0734893311084161
down	IL20RB; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00027658312190115	0.00979249763820704	0.850493099846045	0.874279248329544	0.515449702940045	0.849939933602242	0.0845681814282906
down	CYP1A1; CYP2C9; UGT1A1; CYP2C19; FMO2; UGT1A7;	GO:0017144~drug metabolic process	6	25	24	0.00027658312190115	0.00979249763820704	0.850493099846045	0.874279248329544	0.515449702940045	0.849939933602242	0.0845681814282906
down	CYP2C9; CYP2C19; CYP2F1; CYP2J2; CYP2C18; CYP2S1;	GO:0042738~exogenous drug catabolic process	6	25	24	0.00027658312190115	0.00979249763820704	0.850493099846045	0.874279248329544	0.515449702940045	0.849939933602242	0.0845681814282906
down	FOXP2; ELN; HOXD9; HOXD10; MEOX2; MYH14; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	8	50	16	0.00032230386281684	0.0105488413541677	0.989150554984887	1	0.552751124730884	0.989150554984887	0.0910999790305639
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.00032623560247913	0.0105488413541677	1	1	0.555023292766761	0.999998327340472	0.0910999790305639
down	ALOX15B; ALOX12B; PON3; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	5	16	31.25	0.00032623560247913	0.0105488413541677	1	1	0.555023292766761	0.999998327340472	0.0910999790305639
down	EDN3; EDN2; KEL; EDNRB; BDKRB2;	GO:0042310~vasoconstriction	5	16	31.25	0.00032623560247913	0.0105488413541677	1	1	0.555023292766761	0.999998327340472	0.0910999790305639
down	GJB6; GJB1; GJA1; GJB2;	GO:0016264~gap junction assembly	4	8	50	0.00032704411664297	0.0105488413541677	1	1	0.555529039923224	0.999998327340472	0.0910999790305639
down	AQP1; SCNN1A; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.00032704411664297	0.0105488413541677	1	1	0.555529039923224	0.999998327340472	0.0910999790305639
down	PLA2G10; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	6	26	23.0769230769231	0.00033182410888388	0.0105949091735551	1	1	0.55827277932761	0.999998327340472	0.0914978215271255
down	GABRR1; GABRB2; GABRG1; GABRA4; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	6	27	22.2222222222222	0.00039533988328543	0.0122516605006399	1	1	0.594986524344586	0.999998327340472	0.105805555058132
down	PLA2G10; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	6	27	22.2222222222222	0.00039533988328543	0.0122516605006399	1	1	0.594986524344586	0.999998327340472	0.105805555058132
down	PLPP2; ALDH3B2; DEGS2; FA2H; CERS3; SPTSSB; ACER1; SPTLC3;	GO:0030148~sphingolipid biosynthetic process	8	52	15.3846153846154	0.00040813153789476	0.0122803503289418	1	1	0.602402149932669	0.999998327340472	0.106053320918755
down	GABRQ; GABRB2; HTR3B; GABRA3; GABRR1; GABRE; GABRG1; GABRA4;	GO:0050877~nervous system process	8	52	15.3846153846154	0.00040813153789476	0.0122803503289418	1	1	0.602402149932669	0.999998327340472	0.106053320918755
down	CA2; KRT6A; KRT16; SERPINB5; CA9;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.00041180548398223	0.0122803503289418	1	1	0.604530450485914	0.999998327340472	0.106053320918755
down	AKR1B10; AKR1C3; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	4	9	44.4444444444444	0.00046119770044184	0.0134985734360801	1	1	0.627589880581953	0.999998327340472	0.116573917047637
down	AKR1B10; AKR1C3; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	4	9	44.4444444444444	0.00046119770044184	0.0134985734360801	1	1	0.627589880581953	0.999998327340472	0.116573917047637
down	CLDN5; RAMP3; ALOX12B; DKK1; AGR2; BMP2; BMP7; ERBB3; HOXD3; ID1; LCN2; POU3F1; PKP1; NR0B2; OCLN; SLC26A9; CAMK2N1; SEC16B; OVOL2; EPB41L4B; PKP3; IL1F10; IL36A; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	25	374	6.68449197860963	0.00049538869924248	0.0143062679266128	1	1	0.642849240601041	0.999998327340472	0.123549180840144
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0005008251596601	0.0143062679266128	1	1	0.645215554658973	0.999998327340472	0.123549180840144
down	PLA2G10; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	5	18	27.7777777777778	0.00051326669311802	0.0143062679266128	1	1	0.650822166873649	0.999998327340472	0.123549180840144
down	ALOX12B; GSTA1; CYP2J2; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	5	18	27.7777777777778	0.00051326669311802	0.0143062679266128	1	1	0.650822166873649	0.999998327340472	0.123549180840144
down	CXCL11; CXCL10; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.00055056346508308	0.0151333140271969	1	1	0.66741510905566	0.999998327340472	0.130691565476609
down	CA12; CA2; AQP1; HBA1; CA9; CYB5R2; SLC26A9;	GO:0015701~bicarbonate transport	7	42	16.6666666666667	0.00060971978901558	0.0164728568639168	1	1	0.691422240743672	0.999998327340472	0.142259880918903
down	ALOX12B; PSAPL1; SPNS2; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	5	19	26.3157894736842	0.00063241914455636	0.0167989656801904	1	1	0.700150367023694	0.999998327340472	0.145076162378333
down	PLA2G10; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	5	19	26.3157894736842	0.00063241914455636	0.0167989656801904	1	1	0.700150367023694	0.999998327340472	0.145076162378333
down	SCGB1A1; IDO1; GPNMB; IL20RB; VTCN1; FOXJ1; PLA2G2F;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.00069082273551346	0.0180470303054385	1	1	0.722752447915184	0.999998327340472	0.155854470381228
down	PLPP2; PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PLA2G3; GDPD3; PLA2G2F;	GO:0006644~phospholipid metabolic process	8	57	14.0350877192982	0.00070584317875999	0.0181395958378889	1	1	0.728542058749034	0.999998327340472	0.156653867943677
down	DLX3; CA2; GLI2; BMP2; BMP7; AMTN; SOSTDC1; NKX2-3;	GO:0042475~odontogenesis of dentin-containing tooth	8	57	14.0350877192982	0.00070584317875999	0.0181395958378889	1	1	0.728542058749034	0.999998327340472	0.156653867943677
down	ALOX12B; FA2H; CERS3; SPTSSB; ALOXE3; DEGS2;	GO:0046513~ceramide biosynthetic process	6	31	19.3548387096774	0.000749380596746	0.018950336530513	1	1	0.744134932568786	0.999998327340472	0.163655438790896
down	CLDN5; DKK1; PAX9; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.000749380596746	0.018950336530513	1	1	0.744134932568786	0.999998327340472	0.163655438790896
down	DEFB4A; CXCL14; C1QC; SLPI; HLA-DQB2; CD1A; CTSG; CD1E; ENDOU; FCGR2B; DEFB1; CX3CL1; MS4A2; GBP6; CCL19; IL36B; IL36A; IL19; CXCL10; RAET1G; IGLV3-9; RAET1L; AZGP1; CXCL9; CD1B; RAET1E; CXCL11;	GO:0006955~immune response	27	433	6.23556581986143	0.00081689336864909	0.0201636480361927	1	1	0.764612193055554	0.999998327340472	0.1741336182434
down	FUT1; FUT3; FUT2; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.00083928065557747	0.0201636480361927	1	1	0.771298922475703	0.999998327340472	0.1741336182434
down	IRF6; KLK8; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00083928065557747	0.0201636480361927	1	1	0.771298922475703	0.999998327340472	0.1741336182434
down	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.00085688279571605	0.0201636480361927	1	1	0.776503218897128	0.999998327340472	0.1741336182434
down	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.00085688279571605	0.0201636480361927	1	1	0.776503218897128	0.999998327340472	0.1741336182434
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00085688279571605	0.0201636480361927	1	1	0.776503218897128	0.999998327340472	0.1741336182434
down	AKR1C3; AKR1C2; AKR1C1;	GO:0071395~cellular response to jasmonic acid stimulus	3	4	75	0.00085688279571605	0.0201636480361927	1	1	0.776503218897128	0.999998327340472	0.1741336182434
down	ANXA8; PLA2R1; ANXA1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00085688279571605	0.0201636480361927	1	1	0.776503218897128	0.999998327340472	0.1741336182434
down	SLC6A15; SLC6A17; SLC6A14; SLC6A1; SLC6A11; TMEM184A;	GO:0006810~transport	6	32	18.75	0.00086752803951983	0.0201636480361927	1	1	0.779365288356434	0.999998327340472	0.1741336182434
down	FGF1; ADRA2A; ADRA2C; NTF3; IL18; DYNAP;	GO:0032148~activation of protein kinase B activity	6	32	18.75	0.00086752803951983	0.0201636480361927	1	1	0.779365288356434	0.999998327340472	0.1741336182434
down	PLA2G10; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	5	21	23.8095238095238	0.00093133043749538	0.0214885803862985	1	1	0.792473805463205	0.999998327340472	0.185575757266931
down	WNT9B; DKK1; LRAT; GJA1; IGFBP2; GJB2; AQP3;	GO:0032526~response to retinoic acid	7	46	15.2173913043478	0.00098635343160147	0.0224306704841169	1	1	0.802466412532713	0.999998327340472	0.193711663882139
down	GJB6; CXCL14; C1QB; BMP2; GJB2; HPCA; CYTL1;	GO:0048839~inner ear development	7	46	15.2173913043478	0.00098635343160147	0.0224306704841169	1	1	0.802466412532713	0.999998327340472	0.193711663882139
down	FABP5; SLC44A4; SLC44A3; MFSD2A; SLC44A5; LPIN3;	GO:0006656~phosphatidylcholine biosynthetic process	6	33	18.1818181818182	0.00099951367027872	0.0225675907982219	1	1	0.804783036201077	0.999998327340472	0.194894110117231
down	CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.00109259595283717	0.0244942965029667	1	1	0.821773133863595	0.999998327340472	0.211533174390482
down	OVOL1; GJB3; KRT9; DHCR24; TFAP2B; DSP;	GO:0043588~skin development	6	34	17.6470588235294	0.00114638762781094	0.0251648006354888	1	1	0.831527771375032	0.999998327340472	0.217323659843989
down	FOXP2; TCF21; EDN2; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	6	34	17.6470588235294	0.00114638762781094	0.0251648006354888	1	1	0.831527771375032	0.999998327340472	0.217323659843989
down	NFASC; MAL; UGT8;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00134046036479107	0.0282479680873639	1	1	0.863981457785245	0.999998327340472	0.243949948057393
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.00134046036479107	0.0282479680873639	1	1	0.863981457785245	0.999998327340472	0.243949948057393
down	KRT10; KRT2; TMEM79;	GO:0045684~positive regulation of epidermis development	3	5	60	0.00134046036479107	0.0282479680873639	1	1	0.863981457785245	0.999998327340472	0.243949948057393
down	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.00134046036479107	0.0282479680873639	1	1	0.863981457785245	0.999998327340472	0.243949948057393
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00134046036479107	0.0282479680873639	1	1	0.863981457785245	0.999998327340472	0.243949948057393
down	CYP1A1; HNF1B; HNF4A; ANXA1;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.0013950511788634	0.0292036872608425	1	1	0.872428896481849	0.999998327340472	0.252203555609147
down	SRRM4; GJB1; NTF3; PTN; EDNRB; DLX5; VLDLR; PCDH1; CNTN4; FGF14; ATOH8; LINC01587; NRTN; SDCBP2; PCDHA4; GDA; PCDHB11; ERBB3; GFRA3; TYRO3;	GO:0007399~nervous system development	20	294	6.80272108843537	0.0014140906271265	0.0294075031075451	1	1	0.875322098191301	0.999998327340472	0.253963712837539
down	PIGR; BTC; GRB7; FAM83B; EPGN; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	7	50	14	0.00152551344564644	0.0315173072005778	1	1	0.892653119358908	0.999998327340472	0.272184018004793
down	CXCL14; CXCL10; IL18; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.00156091755785948	0.0318326477444762	1	1	0.898311086473323	0.999998327340472	0.274907304475043
down	CYP1A1; AOC1; GJB2; ID1; HYAL1;	GO:0046677~response to antibiotic	5	24	20.8333333333333	0.00156091755785948	0.0318326477444762	1	1	0.898311086473323	0.999998327340472	0.274907304475043
down	AGR2; PTN; FOXF1; VWC2; EGFLAM; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.00168728705018717	0.034189194651549	1	1	0.915661990998201	0.999998327340472	0.295258484913837
down	AKR1C3; ALDH1A3; AKR1C1; SDR16C5;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.0017513421445271	0.0345999532428135	1	1	0.920286155348122	0.999998327340472	0.298805803315402
down	SCNN1A; SCNN1B; SCNN1G; TFAP2B;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.0017513421445271	0.0345999532428135	1	1	0.920286155348122	0.999998327340472	0.298805803315402
down	COBL; BMP7; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.0017513421445271	0.0345999532428135	1	1	0.920286155348122	0.999998327340472	0.298805803315402
down	CLDN5; GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	4	14	28.5714285714286	0.0017513421445271	0.0345999532428135	1	1	0.920286155348122	0.999998327340472	0.298805803315402
down	CTSV; GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	5	25	20	0.00182733588631745	0.0358770728984438	1	1	0.925788325098203	0.999998327340472	0.309835031070493
down	ZBTB7C; BMP2; SULT1E1; KLF5; MEDAG; CDS1; RARRES2;	GO:0045600~positive regulation of fat cell differentiation	7	52	13.4615384615385	0.001869361834268	0.0364756343093898	1	1	0.928881805056763	0.999998327340472	0.315004217918121
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.00196595339973626	0.0369602227379753	1	1	0.935793818274462	0.999998327340472	0.31918913209025
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.00196595339973626	0.0369602227379753	1	1	0.935793818274462	0.999998327340472	0.31918913209025
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.00196595339973626	0.0369602227379753	1	1	0.935793818274462	0.999998327340472	0.31918913209025
down	ALOX15B; ALOX12B; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.00196595339973626	0.0369602227379753	1	1	0.935793818274462	0.999998327340472	0.31918913209025
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00196595339973626	0.0369602227379753	1	1	0.935793818274462	0.999998327340472	0.31918913209025
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00196595339973626	0.0369602227379753	1	1	0.935793818274462	0.999998327340472	0.31918913209025
down	PHGDH; AKR7A3; IDO1; GPX2; MAOB; XDH; ME1; NDUFA4L2;	GO:0022900~electron transport chain	8	68	11.7647058823529	0.00197604480946467	0.0369602227379753	1	1	0.936580876446164	0.999998327340472	0.31918913209025
down	NFASC; MAL; KEL; ADGRG6; KLK6; MAL2; MALL;	GO:0042552~myelination	7	53	13.2075471698113	0.00206235451498959	0.0383476624816595	1	1	0.942496013350245	0.999998327340472	0.331171086061513
down	CTSV; NRTN; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00216611342144768	0.0395785232670296	1	1	0.950148426134275	0.999998327340472	0.341800821401353
down	ADCYAP1; ADCYAP1R1; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.00216611342144768	0.0395785232670296	1	1	0.950148426134275	0.999998327340472	0.341800821401353
down	PLA2G4D; GDPD3; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	4	15	26.6666666666667	0.00216611342144768	0.0395785232670296	1	1	0.950148426134275	0.999998327340472	0.341800821401353
down	CXCL11; CXCL10; CX3CL1; ACKR1; CCL11; CXCL9; CCL17; CCL19;	GO:0070098~chemokine-mediated signaling pathway	8	70	11.4285714285714	0.00233196365497612	0.0421219263621687	1	1	0.962030121093649	0.999998327340472	0.363765695158972
down	PIGR; TF; KRT1; HSPB1; AZGP1; ZG16B;	GO:0001895~retina homeostasis	6	40	15	0.00240268794548382	0.0431528215663315	1	1	0.966590714089198	0.999998327340472	0.372668524230796
down	GLI2; HOXD10; HOXC10; HOXD9; HOXC9;	GO:0009954~proximal/distal pattern formation	5	27	18.5185185185185	0.00245773043530395	0.0436454264381786	1	1	0.970163236940994	0.999998327340472	0.376922668547593
down	ADCYAP1; ADCYAP1R1; DEFB1; ADGRG6; PCLO;	GO:0019933~cAMP-mediated signaling	5	27	18.5185185185185	0.00245773043530395	0.0436454264381786	1	1	0.970163236940994	0.999998327340472	0.376922668547593
down	MT1X; MT1A; MT1H; MT1M;	GO:0010273~detoxification of copper ion	4	16	25	0.00264393382992567	0.0449765188208398	1	1	0.981461340459801	0.999998327340472	0.388418005720359
down	CXCL10; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	4	16	25	0.00264393382992567	0.0449765188208398	1	1	0.981461340459801	0.999998327340472	0.388418005720359
down	GLI2; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.00264393382992567	0.0449765188208398	1	1	0.981461340459801	0.999998327340472	0.388418005720359
down	NUPR2; WNT9B; CTSV; KRT20; AKR1C3; CADPS2; MFSD2A; MYH13;	GO:0009267~cellular response to starvation	8	72	11.1111111111111	0.00273625111662201	0.0449765188208398	1	1	0.987463568180155	0.999998327340472	0.388418005720359
down	S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	AQP1; AQP2; AQP3;	GO:0015793~glycerol transport	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	IDO1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	PLA2G10; MIF; PLA2R1;	GO:0090238~positive regulation of arachidonic acid secretion	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	NUPR1; IL33; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	ANXA8; SPINK6; SPINK5;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00274611456261376	0.0449765188208398	1	1	0.988010639409064	0.999998327340472	0.388418005720359
down	COBL; CYP1A1; CCNB1; CLDN18; FOXF1;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.00282601446246766	0.0458104190556938	1	1	0.992296238592152	0.999998327340472	0.395619582780646
down	S100A8; S100A9; CTSG; NLRP10; RNASE7;	GO:0050832~defense response to fungus	5	28	17.8571428571429	0.00282601446246766	0.0458104190556938	1	1	0.992296238592152	0.999998327340472	0.395619582780646
down	FUT1; FUT3; FUT6; FUT2; ST6GAL2; ST6GALNAC5; B3GNT6; B3GNT3; B3GALT5;	GO:0006486~protein glycosylation	9	90	10	0.00294066154478689	0.0471849296602608	1	1	0.995340423611068	0.999998327340472	0.407489880479632
down	PPL; SCEL; CCNB1; IGFBP2; BDKRB1; LRP11; PIEZO2;	GO:0009612~response to mechanical stimulus	7	57	12.280701754386	0.00299244354658856	0.0475332364360123	1	1	0.996579689740148	0.999998327340472	0.410497863906611
down	AQP1; AQP2; AQP5; AQP3;	GO:0006833~water transport	4	17	23.5294117647059	0.00318927458933838	0.0499074107767258	1	1	0.999998327340472	0.999998327340472	0.431001275171626
down	ALOX15B; PLA2G10; AGTR1; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	4	17	23.5294117647059	0.00318927458933838	0.0499074107767258	1	1	0.999998327340472	0.999998327340472	0.431001275171626
down	CTSV; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.00318927458933838	0.0499074107767258	1	1	0.999998327340472	0.999998327340472	0.431001275171626
down	BMP7; ITGA8; IRX3; SOX17; ROBO2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00323257516435016	0.0503358132734525	1	1	0.999998327340472	0.999998327340472	0.434700966650352
down	BMP7; HOXD3; LUM; PITX1; HYAL1; HES5; IL17F;	GO:0051216~cartilage development	7	58	12.0689655172414	0.00326841255645016	0.0506443729947988	1	1	0.999998327340472	0.999998327340472	0.437365693818063
down	MSMB; TM4SF1; CRYBA2; KRTDAP; TCHH; RAD51AP2; KRT24; TTC39A; GGT6; SBSN; IGFL2; KRT27; TMPRSS11B; UNC93A; IL22RA1; FIBIN; NKX2-3; GIPC2; TMEM54; SLAMF9; TMEM125; KIF12; GPR87; GCOM2; UACA; PLA2G2F; RNF39; CCM2L; ETNK2; CGN; PSORS1C2; LINC01558;	GO:0008150~biological_process	32	603	5.30679933665008	0.00335247656269211	0.0516935532422915	1	1	0.999998327340472	0.999998327340472	0.446426432844923
down	NFASC; PIGR; SLPI; CSTB; KRT1; S100A8; S100A9; CTSG; MIF; DSP; AOC1; TCN1; SERPINB3; S100A7; S100A11; PRSS3; CEACAM6; CRISP3; LCN2; FABP5; DSG1; PKP1; FLG2; HRNR; GGH; SERPINB12; CALML5;	GO:0043312~neutrophil degranulation	27	483	5.59006211180124	0.00349149769753421	0.053575845737406	1	1	0.999998327340472	0.999998327340472	0.462681943860507
down	CLEC3B; BMP2; PTN; FGFR3; GPNMB; TUFT1;	GO:0030282~bone mineralization	6	44	13.6363636363636	0.00368419946424736	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	AKR1C1; AKR1C3; AKR1C2;	GO:0008207~C21-steroid hormone metabolic process	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	SULT1C2; CYP1A1; AOC1;	GO:0009308~amine metabolic process	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	HOXD9; HOXD10; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	CYP1A1; MAOB; DUOX2;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.00369215893183839	0.0540320110349127	1	1	0.999998327340472	0.999998327340472	0.466621395373911
down	TCF21; HNF1B; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	4	18	22.2222222222222	0.00380648994607236	0.0551941042180492	1	1	0.999998327340472	0.999998327340472	0.476657252494225
down	CXCL10; S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.00380648994607236	0.0551941042180492	1	1	0.999998327340472	0.999998327340472	0.476657252494225
down	OVOL1; TCF21; CA2; GLI2; AGTR1; HNF1B; ITGA8; TFAP2B; STRA6;	GO:0001822~kidney development	9	94	9.57446808510638	0.00383666036415031	0.0553775498222792	1	1	0.999998327340472	0.999998327340472	0.478241491951197
down	FGF1; ADRA2A; EDN3; MIF; MST1R; TPD52L1; EPGN;	GO:0043406~positive regulation of MAP kinase activity	7	60	11.6666666666667	0.00387812949217692	0.0554695354062047	1	1	0.999998327340472	0.999998327340472	0.479035881068009
down	CTSV; S100B; SCGB1A1; IGFBP2; AGXT; ALDH3A1; HSD11B2;	GO:0051384~response to glucocorticoid	7	60	11.6666666666667	0.00387812949217692	0.0554695354062047	1	1	0.999998327340472	0.999998327340472	0.479035881068009
down	ADRA2A; AGTR1; EPS8L1; EPS8L2; RHOD; CDC42EP5; RHOV; RND3;	GO:0007266~Rho protein signal transduction	8	77	10.3896103896104	0.0039872606363508	0.0567735624842562	1	1	0.999998327340472	0.999998327340472	0.490297481795263
down	WNT9B; SPDEF; FGF1; HOXD4; EDN3; HOXB1; FLG; MEOX2; ELF3; ODF4; SPATA19; CCL17; AMN; PAQR5; EHF; NPAP1; THEG; DKK4; NKX1-2; TYRO3; FGFR3; CDH19; CDH8; ERBB3; MST1R; SPINK6; CDH17; SPINK5;	GO:0007275~multicellular organism development	28	513	5.45808966861598	0.00405560988439935	0.0574730573273252	1	1	0.999998327340472	0.999998327340472	0.496338331533741
down	DEFB4A; KRT6A; DEFB1; LCE3A; PGLYRP4; PGLYRP3; RARRES2; RNASE7; GBP6;	GO:0050830~defense response to Gram-positive bacterium	9	95	9.47368421052632	0.00409093258419746	0.0574730573273252	1	1	0.999998327340472	0.999998327340472	0.496338331533741
down	GLI2; HOXB1; SOSTDC1; GRHL3; FOXJ1;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.00416917768087	0.0580562583666522	1	1	0.999998327340472	0.999998327340472	0.501374865942547
down	ERBB3; BTC; PTK6; GRB7; PTPRR;	GO:0038128~ERBB2 signaling pathway	5	31	16.1290322580645	0.00416917768087	0.0580562583666522	1	1	0.999998327340472	0.999998327340472	0.501374865942547
down	NKX2-8; S100B; CCK; S100A6; MAP2; PTPRZ1; CNTN4; PARD3;	GO:0007409~axonogenesis	8	78	10.2564102564103	0.00428319141132105	0.059382316013973	1	1	0.999998327340472	0.999998327340472	0.512826723052571
down	ZBTB7C; NUPR2; SULT2B1; IRF6; ALOX15B; GJB6; TFF1; BMP2; NPPC; AZGP1; S100A11; HNF4A; CDKN2B; SLURP1; DPT; FGFBP1; GPNMB; DHCR24; BNIPL; CAMK2N1; TFAP2B; SOX7; NUPR1;	GO:0008285~negative regulation of cell population proliferation	23	396	5.80808080808081	0.00434342003594068	0.0599543700157576	1	1	0.999998327340472	0.999998327340472	0.517766991449568
down	KLK8; GJA1; BMP7; UGT8; NYAP1; NTF3; NTF4;	GO:0048812~neuron projection morphogenesis	7	62	11.2903225806452	0.00457039897074696	0.0628131788979615	1	1	0.999998327340472	0.999998327340472	0.542455715118567
down	PRLR; GJA1; ADCYAP1; ESRRG; LCN2; FABP5; IL18; FFAR4; DIO2;	GO:0120162~positive regulation of cold-induced thermogenesis	9	97	9.27835051546392	0.00463881810044464	0.0634775065606299	1	1	0.999998327340472	0.999998327340472	0.548192860470043
down	SCNN1B; SCNN1G; AMN; UGT1A7; ATP6V0A4;	GO:0007588~excretion	5	32	15.625	0.00470352097513871	0.0639353936716428	1	1	0.999998327340472	0.999998327340472	0.552147181595098
down	SFN; KRT2; EXPH5;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.00481386387024707	0.0639353936716428	1	1	0.999998327340472	0.999998327340472	0.552147181595098
down	FUT1; FUT6; FUT2;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.00481386387024707	0.0639353936716428	1	1	0.999998327340472	0.999998327340472	0.552147181595098
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00481386387024707	0.0639353936716428	1	1	0.999998327340472	0.999998327340472	0.552147181595098
down	ELN; NPPC; PDE1A;	GO:0048660~regulation of smooth muscle cell proliferation	3	9	33.3333333333333	0.00481386387024707	0.0639353936716428	1	1	0.999998327340472	0.999998327340472	0.552147181595098
down	AGTR1; APLNR; FGFBP1;	GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	9	33.3333333333333	0.00481386387024707	0.0639353936716428	1	1	0.999998327340472	0.999998327340472	0.552147181595098
down	FGF1; PTN; BTC; MACC1; GAREM1; GKN1;	GO:0051781~positive regulation of cell division	6	47	12.7659574468085	0.00493485415411676	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	PLA2G10; LIPK; LIPI; ASPG; PLA2G2F; PLA2G3; PNLIPRP3; CES3;	GO:0016042~lipid catabolic process	8	81	9.87654320987654	0.0052729948460114	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	CYP1A1; CYP2C9; UGT1A1; SULT1E1;	GO:0008210~estrogen metabolic process	4	20	20	0.00527327629657415	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	EDN3; EDN2; HRC; NMU;	GO:0010460~positive regulation of heart rate	4	20	20	0.00527327629657415	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	ADCYAP1; HNF1B; FAM3B; PCLO; ANXA1;	GO:0030073~insulin secretion	5	33	15.1515151515152	0.00528473202603719	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	AQP1; AQP5; PAX9; AQP3; TUFT1;	GO:0042476~odontogenesis	5	33	15.1515151515152	0.00528473202603719	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	SAA1; CX3CL1; CCL19; CCL17; CCL11;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.00528473202603719	0.064498215962562	1	1	0.999998327340472	0.999998327340472	0.557007724775076
down	SNCG; CSTB; HOXD9; HOXD10; NTF4; PREX2;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00541367350376787	0.0658177767131163	1	1	0.999998327340472	0.999998327340472	0.568403474570627
down	CFAP69; OVOL1; CTSV; GJB3; CCNB1; GJA1; TSPAN8; KRT9; ADCYAP1R1; HSPA2; BNC1; TYRO3; WFDC2; ODF4; SHISA6; SPATA19; HORMAD1; FOXJ1; SOX17; BCL2L10; NPAP1; THEG; GGT5;	GO:0007283~spermatogenesis	23	407	5.65110565110565	0.00589164195605263	0.0709499548993353	1	1	0.999998327340472	0.999998327340472	0.612725055438932
down	AQP1; AQP2; TFAP2B; AQP3; MYO5B;	GO:0003091~renal water homeostasis	5	34	14.7058823529412	0.00591491119603926	0.0709499548993353	1	1	0.999998327340472	0.999998327340472	0.612725055438932
down	C2CD4B; PRLR; FUT1; FUT2; IL18; SPINK5;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.00592558940000776	0.0709499548993353	1	1	0.999998327340472	0.999998327340472	0.612725055438932
down	EMP1; EMP2; LPAR3;	GO:0032060~bleb assembly	3	10	30	0.00611966372122352	0.0716049205936557	1	1	0.999998327340472	0.999998327340472	0.618381350667484
down	AKR1C3; AKR1C2; AKR1C1;	GO:0042448~progesterone metabolic process	3	10	30	0.00611966372122352	0.0716049205936557	1	1	0.999998327340472	0.999998327340472	0.618381350667484
down	PLA2G10; MIF; SLC7A2;	GO:0043030~regulation of macrophage activation	3	10	30	0.00611966372122352	0.0716049205936557	1	1	0.999998327340472	0.999998327340472	0.618381350667484
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00611966372122352	0.0716049205936557	1	1	0.999998327340472	0.999998327340472	0.618381350667484
down	CLDN1; TJP1; OCLN; MARVELD2;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00613082783360874	0.0716049205936557	1	1	0.999998327340472	0.999998327340472	0.618381350667484
down	SRPX2; ANXA1; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.00613082783360874	0.0716049205936557	1	1	0.999998327340472	0.999998327340472	0.618381350667484
down	CLDN5; IRF6; WNT9B; TCF21; MEOX2; DLX5; FOXF2;	GO:0060021~roof of mouth development	7	66	10.6060606060606	0.0062295369394102	0.0723954642113075	1	1	0.999998327340472	0.999998327340472	0.625208499220853
down	KLK8; BRINP1; CIDEA; EMP1; EMP2;	GO:0008219~cell death	5	35	14.2857142857143	0.00659612884847705	0.0755447945291157	1	1	0.999998327340472	0.999998327340472	0.652406171105386
down	EDN2; NMU; IRX3; MFSD2A; MRAP2;	GO:0097009~energy homeostasis	5	35	14.2857142857143	0.00659612884847705	0.0755447945291157	1	1	0.999998327340472	0.999998327340472	0.652406171105386
up	IRGM; ACOD1; BMPR1B; CCL21; NCR3; HYAL3; IL18RAP; LY86; KNG1; CALCA; TNF; ORM1; IL5; ADORA3; TMIGD3; CYBA; CCL2; FOLR2; ALOX15; SELP; ITGB6; TNFRSF1A; F2R; CD40LG; AXL; AKT1; CCR7; CNR2; LIPA; MAP2K3; CXCR3; CSRP3; AIF1; GSDMD; TIRAP; NLRP6; ADAM8; RELA; FUT7; NAIP; NMI; TCIRG1; NFATC4; PRKD1; GPR68; CDO1; NLRP9; PLD3; IL27; TNIP2; NFKBID; PLD4; CD180; IL22; PROK2; TLR9; PYCARD; MFHAS1; PF4; CD14; PTGDR; CCL8; NFKB2; PPBP; CCL24; CCL7; RELB; CCL26; TNFRSF4; PTGIR; CCR5; FPR3; TBXA2R; CCR2; TNFSF4; XCL2; IL2RA; CXCL3;	GO:0006954~inflammatory response	78	381	20.4724409448819	0.00670611399790322	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	CCNB1; PTN; TM4SF4; KLK6;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.00707619099654933	0.0798851419289015	1	1	0.999998327340472	0.999998327340472	0.689889487408141
down	CSTA; CSTB; SERPINB3; CAMK2N1;	GO:0045861~negative regulation of proteolysis	4	22	18.1818181818182	0.00707619099654933	0.0798851419289015	1	1	0.999998327340472	0.999998327340472	0.689889487408141
up	FCN1; C1R; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGHV1-46; IGHV3-13; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; C1S; IGLC2; IGLC3; IGHV1-2; MASP1; RGCC;	GO:0006956~complement activation	25	92	27.1739130434783	0.0072442598336383	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	CXCL10; EDN3; ELN; BDKRB2; MEOX2;	GO:0008015~blood circulation	5	36	13.8888888888889	0.00733042027363884	0.0824607063522148	1	1	0.999998327340472	0.999998327340472	0.712132106960193
down	S100A8; S100A9; CX3CL1;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.00761673957023246	0.0850760204293455	1	1	0.999998327340472	0.999998327340472	0.734718005220083
down	SCGB1A1; NQO1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	6	52	11.5384615384615	0.00767262464373375	0.0853984735874732	1	1	0.999998327340472	0.999998327340472	0.73750271635162
down	ANXA1; ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.00811291962476246	0.0857467691816065	1	1	0.999998327340472	0.999998327340472	0.740510603213947
down	TCF21; EPCAM; BMP7; NPNT; ROBO2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00811978087832721	0.0857467691816065	1	1	0.999998327340472	0.999998327340472	0.740510603213947
down	GLI2; BMP2; FGFR3; HES5; CYTL1;	GO:0002062~chondrocyte differentiation	5	37	13.5135135135135	0.00811978087832721	0.0857467691816065	1	1	0.999998327340472	0.999998327340472	0.740510603213947
down	GCNT3; GALNT18; A4GNT; B3GALT5; B3GNT6; B3GNT3;	GO:0006493~protein O-linked glycosylation	6	53	11.3207547169811	0.0083295977919039	0.0857467691816065	1	1	0.999998327340472	0.999998327340472	0.740510603213947
down	ADCYAP1; EDNRB; BDKRB1; NMU; DLG2; ALOXE3;	GO:0019233~sensory perception of pain	6	53	11.3207547169811	0.0083295977919039	0.0857467691816065	1	1	0.999998327340472	0.999998327340472	0.740510603213947
down	CLDN5; CXCL10; PTN; EFNA3; ECSCR; IL17F; SPINK5; PLK2;	GO:0016525~negative regulation of angiogenesis	8	89	8.98876404494382	0.0087674329533266	0.0888264601457224	1	1	0.999998327340472	0.999998327340472	0.767106868418063
down	CLDN1; OCLN; MARVELD2; PARD3; POF1B;	GO:0070830~bicellular tight junction assembly	5	38	13.1578947368421	0.00896616164520059	0.0905496388513708	1	1	0.999998327340472	0.999998327340472	0.781988269955916
down	CX3CL1; CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.00924437727537031	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	DKK1; SOX7; SOX17;	GO:0001706~endoderm formation	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	ADH7; ALDH3B2; SULT1E1;	GO:0006068~ethanol catabolic process	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	ADH1B; ADH1C; ADH7;	GO:0006069~ethanol oxidation	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	EDNRB; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	CHST9; DIO2; DUOX2;	GO:0042446~hormone biosynthetic process	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	MFSD2A; MAL2; RAB17;	GO:0045056~transcytosis	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	EDN3; EDN2; GPR62;	GO:0048016~inositol phosphate-mediated signaling	3	12	25	0.00931110429892512	0.0914049710835475	1	1	0.999998327340472	0.999998327340472	0.78937493412114
down	RGS5; RGS11; ERBB3; PTK6; RGS7BP;	GO:0009968~negative regulation of signal transduction	5	39	12.8205128205128	0.00987146486396795	0.0960113859538544	1	1	0.999998327340472	0.999998327340472	0.829156013767886
down	DKK1; BMP7; HOXD10; DLX5; HOXC10;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.00987146486396795	0.0960113859538544	1	1	0.999998327340472	0.999998327340472	0.829156013767886
down	MT1A; AKR1C3; MT1H; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	5	39	12.8205128205128	0.00987146486396795	0.0960113859538544	1	1	0.999998327340472	0.999998327340472	0.829156013767886
down	MT1A; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	4	25	16	0.0104737308301567	0.101246064691515	1	1	0.999998327340472	0.999998327340472	0.874362791196971
down	DHCR24; DUOXA1; DUOXA2; PHYHIP; WNK4; SLC9A2; PARD3;	GO:0008104~protein localization	7	74	9.45945945945946	0.0108373734738294	0.103810498082226	1	1	0.999998327340472	0.999998327340472	0.89650928295616
down	CXCL14; AGTR1; CX3CL1; ARHGEF16; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	7	74	9.45945945945946	0.0108373734738294	0.103810498082226	1	1	0.999998327340472	0.999998327340472	0.89650928295616
down	BMP2; BMP7; FOXF2; AKNAD1; FAM83D;	GO:0001837~epithelial to mesenchymal transition	5	40	12.5	0.0108375401351264	0.103810498082226	1	1	0.999998327340472	0.999998327340472	0.89650928295616
down	KRT1; SAA1; TYRO3; FOXF1; FFAR4; CXCL17; IL22RA2; FNDC4;	GO:0050728~negative regulation of inflammatory response	8	93	8.60215053763441	0.0110550626132333	0.105574178007343	1	1	0.999998327340472	0.999998327340472	0.911740453736002
down	CPZ; CPXM1; CPE;	GO:0006518~peptide metabolic process	3	13	23.0769230769231	0.011207683148021	0.106070318655372	1	1	0.999998327340472	0.999998327340472	0.916025133077952
down	NQO1; NOS2; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.011207683148021	0.106070318655372	1	1	0.999998327340472	0.999998327340472	0.916025133077952
down	ID1; CX3CL1; SYNPO2L;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.011207683148021	0.106070318655372	1	1	0.999998327340472	0.999998327340472	0.916025133077952
down	GJB3; GJB5; TRIP10; CCL19;	GO:0007154~cell communication	4	26	15.3846153846154	0.0118039454368605	0.109218143895314	1	1	0.999998327340472	0.999998327340472	0.943209807083619
down	SLC7A2; SLC38A3; SLC6A15; SLC6A14; SLC25A48;	GO:0006865~amino acid transport	5	41	12.1951219512195	0.0118661806459975	0.109218143895314	1	1	0.999998327340472	0.999998327340472	0.943209807083619
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; TRDV2; TRDV3; IRGM; LILRA5; CD300LB; TYROBP; LY86; NCR2; C1R; TRGV3; C4BPA; CD14; C1S; NLRP2B; DEFA4; CYBA; TRIM27; GATA3; KLRC2; PML; AXL; KIR2DS4; GSDMD; TIRAP; NLRP6; LILRA4; B2M; ADARB1; ARID5A; SIGLEC14; NAIP; SLAMF1; PRKD1; CD300E; AKIRIN2; CLEC6A; TNFAIP8L2; TREML4; NLRP9; TREML1; RNF135; APOBEC3F; LILRA2; DEFB108B; IL27; CLEC4C; TNFRSF14; RNASE6; TMEM106A; PLD4; OPTN; TRIM11; SIGLEC10; PGLYRP2; CD180; TRGV9; ELF4; CNPY3; POLR3C; TRIM8; TRIM4; CARD9; LY9; TLR9; TLR8; APOBEC3C; TLR7; MSRB1; CD84; FBXO9; PYCARD; CLEC4A; MFHAS1; TRDC; IGHV3-16; IGHV3-35; RELB; RELA; TRBC1; NFKB2; TRBC2; IGLC3; IGHV3-13; IGHV1-2; IGHV1-18; IGHV1-46; IGLC2; BPI; IGHV4-34; IGHE; IGHD; IGHV3-43;	GO:0045087~innate immune response	97	505	19.2079207920792	0.0124263248646387	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	TSPAN15; BMP7; NRARP; CHAC1; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	5	42	11.9047619047619	0.0129591197197905	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	CLDN10; SLC5A12; SLC26A9; SLC5A8; SLC5A5; WNK4; SLC25A10; SLC9A2;	GO:0006811~ion transport	8	96	8.33333333333333	0.0130396632522531	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	SMIM22; GRHL3; FZD10; ARHGAP40; RND3; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	7	77	9.09090909090909	0.0130785476548216	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	NUPR1; DKK1; CLDN7; CRYAB; ANXA1; HSPB1; KRT18; CEACAM5; GLI2; MIF; NQO1; EPCAM; PRLR; EDNRB; AQP1; BTC; ID1; CX3CL1; DHCR24; FFAR4; VTCN1; TFAP2B; BCL2L10; PLK2; HIGD1A;	GO:0043066~negative regulation of apoptotic process	25	489	5.11247443762781	0.01313266082065	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	BMP7; ID4; IRX3; HES5; CNTN4; NOTCH3;	GO:0045665~negative regulation of neuron differentiation	6	59	10.1694915254237	0.0131407847344368	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	TF; BMP2; BMP7; HNF4A; ATOH8; INHA;	GO:0060395~SMAD protein signal transduction	6	59	10.1694915254237	0.0131407847344368	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	ALOX15B; PLA2G10; ALOX12B; ALOXE3;	GO:0019369~arachidonic acid metabolic process	4	27	14.8148148148148	0.0132377806761401	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	AGTR1; AKR1C3; XDH; ACE2;	GO:2000379~positive regulation of reactive oxygen species metabolic process	4	27	14.8148148148148	0.0132377806761401	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	FUT3; ST6GALNAC5; B3GALT5;	GO:0009312~oligosaccharide biosynthetic process	3	14	21.4285714285714	0.0133103899985492	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	EDNRB; BTC; TFAP2B;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.0133103899985492	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	FOXP2; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.0133103899985492	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	GCNT3; ADRA2A; MOGAT2;	GO:0050892~intestinal absorption	3	14	21.4285714285714	0.0133103899985492	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	SCNN1A; SCNN1B; SCNN1G;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0133103899985492	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	RAMP3; MMP3; MMP12;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.0133103899985492	0.112799310416659	1	1	0.999998327340472	0.999998327340472	0.974136823999142
down	IL33; S100A8; S100A9; AGTR1; CX3CL1; IL18; NLRP10;	GO:0050729~positive regulation of inflammatory response	7	78	8.97435897435897	0.0138944323870226	0.116809310572815	1	1	0.999998327340472	0.999998327340472	1
down	NKX2-8; NUPR1; KRT4; PTN; CDKN2B; A4GNT;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.0140985264553075	0.117439698283252	1	1	0.999998327340472	0.999998327340472	1
down	RGS5; RGS11; ADCYAP1; GNG4; KCTD8;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	5	43	11.6279069767442	0.0141180276329123	0.117439698283252	1	1	0.999998327340472	0.999998327340472	1
down	MMP3; MMP7; COL15A1; MMP12; KLK6;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.0141180276329123	0.117439698283252	1	1	0.999998327340472	0.999998327340472	1
down	DSP; CDH8; CDH17; NECTIN4; CDH19;	GO:0034332~adherens junction organization	5	43	11.6279069767442	0.0141180276329123	0.117439698283252	1	1	0.999998327340472	0.999998327340472	1
down	RAB38; ATP6V1C2; ATP6V0A4; SLAMF8;	GO:0090383~phagosome acidification	4	28	14.2857142857143	0.0147777878534112	0.122605216285126	1	1	0.999998327340472	0.999998327340472	1
up	PSMB11; TNFSF11; TNFRSF13B; TNFSF12; TNFSF13; TNF; TNFRSF1A; TNFSF4; PSMA2; CD27; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; PSMB10; TNFRSF4; LIMS1; TNFRSF17; RELA; PSME1; TRADD; COMMD7; PSMA8; PSMF1; TNFRSF14; CDIP1; PYCARD; TNFRSF18;	GO:0033209~tumor necrosis factor-mediated signaling pathway	29	120	24.1666666666667	0.0150567655506497	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	ANXA1; CX3CL1; CCL17; CCL19; CCL11;	GO:0002548~monocyte chemotaxis	5	44	11.3636363636364	0.0153445086984034	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	GGT5; GGT6; CHAC1;	GO:0006750~glutathione biosynthetic process	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	SOX18; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	CIDEA; FCGR2B; FFAR4;	GO:0050710~negative regulation of cytokine secretion	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	CIDEA; APOC1; ADRA2A;	GO:0050995~negative regulation of lipid catabolic process	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	BRINP1; SRPX2; MYH14;	GO:0071625~vocalization behavior	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	COBL; EPS8L1; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	ID1; KLF5; KLF15;	GO:1901653~cellular response to peptide	3	15	20	0.0156221995693688	0.125334448829378	1	1	0.999998327340472	0.999998327340472	1
down	CLDN5; PTN; SLC6A1; ARC; STRA6; PAK5;	GO:0007612~learning	6	62	9.67741935483871	0.0161577098172132	0.127813768443716	1	1	0.999998327340472	0.999998327340472	1
down	CD1B; AZGP1; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	4	29	13.7931034482759	0.0164263083211442	0.127813768443716	1	1	0.999998327340472	0.999998327340472	1
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.0164263083211442	0.127813768443716	1	1	0.999998327340472	0.999998327340472	1
down	ADRA2C; EDNRB; FABP5; TMEM100;	GO:0051930~regulation of sensory perception of pain	4	29	13.7931034482759	0.0164263083211442	0.127813768443716	1	1	0.999998327340472	0.999998327340472	1
down	RHOD; AIF1L; RND3; PLS3; PLS1;	GO:0051017~actin filament bundle assembly	5	45	11.1111111111111	0.0166400986132006	0.127813768443716	1	1	0.999998327340472	0.999998327340472	1
down	FOXH1; FOLR1; SOX18; OVOL2; SOX17; NDRG4;	GO:0001947~heart looping	6	63	9.52380952380952	0.0172612632310231	0.128990196390695	1	1	0.999998327340472	0.999998327340472	1
down	SPTBN2; ADGRF1; PCDHB10; PCDHB5; PCDHB11; PCLO;	GO:0007416~synapse assembly	6	63	9.52380952380952	0.0172612632310231	0.128990196390695	1	1	0.999998327340472	0.999998327340472	1
up	TNF; APOA2; CD74; RELA; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	7	15	46.6666666666667	0.0173076859894928	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	S100A8; S100A9; SFN; KRT17; HYAL1; SLC44A4; MFSD2A;	GO:0030307~positive regulation of cell growth	7	82	8.53658536585366	0.0175231597795386	0.130638462413022	1	1	0.999998327340472	0.999998327340472	1
down	CLDN5; FOXH1; ELN; SOX18; SOX17;	GO:0003151~outflow tract morphogenesis	5	46	10.8695652173913	0.0180062620617385	0.133684370552859	1	1	0.999998327340472	0.999998327340472	1
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.0181452157220969	0.133684370552859	1	1	0.999998327340472	0.999998327340472	1
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0181452157220969	0.133684370552859	1	1	0.999998327340472	0.999998327340472	1
down	INHA; BMP7; CDKN2B;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.0181452157220969	0.133684370552859	1	1	0.999998327340472	0.999998327340472	1
down	MMP7; PTN; ANXA1;	GO:0044849~estrous cycle	3	16	18.75	0.0181452157220969	0.133684370552859	1	1	0.999998327340472	0.999998327340472	1
down	MT1X; MT1A; MT1H; MT1M;	GO:0006882~cellular zinc ion homeostasis	4	30	13.3333333333333	0.0181854727420846	0.133684370552859	1	1	0.999998327340472	0.999998327340472	1
up	TNF; IFNG; IFNGR1; LRPAP1; MYOCD;	GO:1900222~negative regulation of amyloid-beta clearance	5	8	62.5	0.018727254523796	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	CEACAM5; CEACAM6; LGALS7; NECTIN4; IGSF21;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	5	47	10.6382978723404	0.0194443905712669	0.142277126379108	1	1	0.999998327340472	0.999998327340472	1
down	TFF1; GJA1; BMP7; GNAI1; ANXA1;	GO:0043434~response to peptide hormone	5	47	10.6382978723404	0.0194443905712669	0.142277126379108	1	1	0.999998327340472	0.999998327340472	1
down	HSPB1; CYP1A1; CCL11; LCN2; MST1R; HYAL1; CCL19; DUOX2;	GO:0009615~response to virus	8	104	7.69230769230769	0.0195908622840127	0.142910331240511	1	1	0.999998327340472	0.999998327340472	1
down	ESYT3; VLDLR; ABCA12; SPNS2; SLCO2A1; GULP1;	GO:0006869~lipid transport	6	65	9.23076923076923	0.0196213488637715	0.142910331240511	1	1	0.999998327340472	0.999998327340472	1
down	CLDN1; LCN2; HYAL1; OCLN; NPNT; CX3CL1; CCL17; CCL19; CCL11;	GO:0071356~cellular response to tumor necrosis factor	9	125	7.2	0.0198126025368467	0.143971578434419	1	1	0.999998327340472	0.999998327340472	1
down	CA2; KRT14; S100A8; GGH;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0200572012101914	0.144750714669897	1	1	0.999998327340472	0.999998327340472	1
down	SLPI; CTSG; DEFB1; RNASE7;	GO:0019731~antibacterial humoral response	4	31	12.9032258064516	0.0200572012101914	0.144750714669897	1	1	0.999998327340472	0.999998327340472	1
down	S100A8; S100A9; TJP1; CAPN6;	GO:0051493~regulation of cytoskeleton organization	4	31	12.9032258064516	0.0200572012101914	0.144750714669897	1	1	0.999998327340472	0.999998327340472	1
down	DIO2; SLC5A5; DUOX2;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.0208807360560022	0.149646234642623	1	1	0.999998327340472	0.999998327340472	1
down	S100A6; MIF; CCNB1; AQP1; BTC;	GO:0048146~positive regulation of fibroblast proliferation	5	48	10.4166666666667	0.0209558006146446	0.149646234642623	1	1	0.999998327340472	0.999998327340472	1
down	TJP1; MYH14; EPB41L4B; LIMCH1;	GO:0031032~actomyosin structure organization	4	32	12.5	0.0220432041513849	0.149646234642623	1	1	0.999998327340472	0.999998327340472	1
down	KRT1; ID1; EMP2; GPNMB;	GO:0045765~regulation of angiogenesis	4	32	12.5	0.0220432041513849	0.149646234642623	1	1	0.999998327340472	0.999998327340472	1
down	CTSV; GJA1; HNF1B; HNF4A; GYS2; NR0B2;	GO:0009749~response to glucose	6	67	8.95522388059701	0.0221917722587877	0.149646234642623	1	1	0.999998327340472	0.999998327340472	1
down	KLK8; SNCG; NFASC; C1QA; PCDHGC4;	GO:0050808~synapse organization	5	49	10.2040816326531	0.0225417319524912	0.151283258390286	1	1	0.999998327340472	0.999998327340472	1
down	S100A8; CCK; S100A9; XDH; FAM162A; BCL2L10; CASP14;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	7	87	8.04597701149425	0.0229366920216679	0.153607803984094	1	1	0.999998327340472	0.999998327340472	1
down	GPR37; NMB; CPE; ADCYAP1; NMU; TYRO3; QRFPR; GPR1;	GO:0007218~neuropeptide signaling pathway	8	108	7.40740740740741	0.023621735584338	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	POU3F1; ADGRG6; PARD3;	GO:0022011~myelination in peripheral nervous system	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	GLI2; BMP7; HNF1B;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	IL18; RAET1G; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	EDN2; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	SULT2B1; SULT1C2; SULT1E1;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	RNASE1; AZGP1; RNASE7;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	FGF1; FUT1; TJP1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0238293129671253	0.156925954768923	1	1	0.999998327340472	0.999998327340472	1
down	ERBB3; TYRO3; NYAP1; PREX2;	GO:0014065~phosphatidylinositol 3-kinase signaling	4	33	12.1212121212121	0.0241449839302041	0.157745932706584	1	1	0.999998327340472	0.999998327340472	1
down	TCF21; CDKN2B; CDH17; NKX2-3;	GO:0048536~spleen development	4	33	12.1212121212121	0.0241449839302041	0.157745932706584	1	1	0.999998327340472	0.999998327340472	1
down	BMP2; BMP7; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	4	33	12.1212121212121	0.0241449839302041	0.157745932706584	1	1	0.999998327340472	0.999998327340472	1
down	PTN; CX3CL1; CNTN4; FGF14; PLK2;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.0242033462077486	0.157745932706584	1	1	0.999998327340472	0.999998327340472	1
down	EGFL8; TFAP2B; HNF4A; HNF4G; TFAP2C;	GO:0048856~anatomical structure development	5	50	10	0.0242033462077486	0.157745932706584	1	1	0.999998327340472	0.999998327340472	1
down	GPR37; ALOX12B; ADRA2A; BMP2; ADRA2C; FGFR3; CX3CL1; WWC1;	GO:0043410~positive regulation of MAPK cascade	8	109	7.3394495412844	0.024713954795493	0.160742409688381	1	1	0.999998327340472	0.999998327340472	1
down	WNT9B; GJB3; AQP1; PTK6; FZD10; BRINP1;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.0249796917475967	0.162137177852471	1	1	0.999998327340472	0.999998327340472	1
up	IGHD; ORM1; ORM2; PANX3; HMGB1P1;	GO:0050716~positive regulation of interleukin-1 secretion	5	9	55.5555555555556	0.0260942025246187	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	RAMP3; DKK1; AKR1C3; HBA1;	GO:0010942~positive regulation of cell death	4	34	11.7647058823529	0.0263638370954453	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	MAP2; VLDLR; PREX2; DCDC2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.0263638370954453	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	DLX3; DLX5; DLG2;	GO:0009790~embryo development	3	19	15.7894736842105	0.0269908113388595	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	MYO5B; MYO1A; MYO5C;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0269908113388595	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	PTN; PTPRZ1; HES5;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.0269908113388595	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	CIDEA; CIDEC; HILPDA;	GO:0034389~lipid droplet organization	3	19	15.7894736842105	0.0269908113388595	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	HOXD10; STRA6; HOXC10;	GO:0050905~neuromuscular process	3	19	15.7894736842105	0.0269908113388595	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	UNC13B; NTF4; GABRB2;	GO:0060384~innervation	3	19	15.7894736842105	0.0269908113388595	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	BMP7; HNF4A; ESRRG; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	5	52	9.61538461538462	0.0277578722982108	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
down	NUPR1; NQO1; CYP2F1; SLC6A1; SLC6A14; PON3;	GO:0009636~response to toxic substance	6	71	8.45070422535211	0.0279916841617206	0.167587041627212	1	1	0.999998327340472	0.999998327340472	1
up	OGG1; APOA2; TNFSF4; EIF2AK1; HP; HPR;	GO:0002526~acute inflammatory response	6	13	46.1538461538462	0.0279935296995738	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	CD74; CD19; CD27; PRKCD; TCIRG1; TLR8;	GO:0016064~immunoglobulin mediated immune response	6	13	46.1538461538462	0.0279935296995738	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	MUC1; MUC3A; MUC21; CLEC10A; MUC15; MUC16; MUCL1; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	8	112	7.14285714285714	0.0282013541607924	0.168197133023141	1	1	0.999998327340472	0.999998327340472	1
down	IDO1; RAET1L; CD300LG; IRF6;	GO:0002376~immune system process	4	35	11.4285714285714	0.0287008571982703	0.169576466549033	1	1	0.999998327340472	0.999998327340472	1
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0287008571982703	0.169576466549033	1	1	0.999998327340472	0.999998327340472	1
down	PTPN3; BTC; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	4	35	11.4285714285714	0.0287008571982703	0.169576466549033	1	1	0.999998327340472	0.999998327340472	1
down	NUPR1; S100A8; S100A9; IL20RA;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	4	35	11.4285714285714	0.0287008571982703	0.169576466549033	1	1	0.999998327340472	0.999998327340472	1
down	FOXH1; FOXF1; IL1F10; IL1RL2; CRNN;	GO:0071345~cellular response to cytokine stimulus	5	53	9.43396226415094	0.0296527069825634	0.174547871083581	1	1	0.999998327340472	0.999998327340472	1
down	EPCAM; HNF4A; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0303644630239874	0.178074336955147	1	1	0.999998327340472	0.999998327340472	1
down	GJA1; ADCYAP1; NPPC;	GO:0097755~positive regulation of blood vessel diameter	3	20	15	0.0303644630239874	0.178074336955147	1	1	0.999998327340472	0.999998327340472	1
up	TNF; APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0305033390779421	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	ADRA2A; NMB; HNF4A; FOXA1; FAM3B; FABP5; ADGRF5; TFAP2B;	GO:0042593~glucose homeostasis	8	114	7.01754385964912	0.0307065645251936	0.179747130489143	1	1	0.999998327340472	0.999998327340472	1
down	CXCL10; HSPA2; CDH8; LRP11;	GO:0009409~response to cold	4	36	11.1111111111111	0.0311569381258672	0.181710482317096	1	1	0.999998327340472	0.999998327340472	1
down	HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.0311569381258672	0.181710482317096	1	1	0.999998327340472	0.999998327340472	1
down	SULT2B1; APOC1; CYP2C9; VLDLR; NR0B2; CH25H;	GO:0008203~cholesterol metabolic process	6	73	8.21917808219178	0.0312337140343325	0.181822780962293	1	1	0.999998327340472	0.999998327340472	1
up	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	SAT2; SAT1; SATL1;	GO:0032918~spermidine acetylation	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	ADA; DPP4; FERMT3;	GO:0033632~regulation of cell-cell adhesion mediated by integrin	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	BCL3; GATA3; BATF;	GO:0045064~T-helper 2 cell differentiation	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	DRD2; GNB3; DRD3;	GO:0090325~regulation of locomotion involved in locomotory behavior	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	NECAB2; SHANK3; UNC13A;	GO:1900451~positive regulation of glutamate receptor signaling pathway	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	OAZ2; OAZ1; OAZ3;	GO:1902268~negative regulation of polyamine transmembrane transport	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0317080970479926	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	ERBB3; PTPRZ1; GABRB2; TYRO3; UNC5B; TFAP2B; FOXQ1; NTF4; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	9	138	6.52173913043478	0.0333711907987403	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
down	DLX3; GJB3; ETNK2; PHLDA2;	GO:0001890~placenta development	4	37	10.8108108108108	0.0337327778936344	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
down	FOXN1; DKK1; HOXC13; SOX18;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.0337327778936344	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
down	SOX18; HES5; ANGPTL8; CCL19;	GO:0048469~cell maturation	4	37	10.8108108108108	0.0337327778936344	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
down	PLPP2; FUT3; FUT6;	GO:0006672~ceramide metabolic process	3	21	14.2857142857143	0.0339489182707591	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
down	TCN1; PRSS3; AMN;	GO:0009235~cobalamin metabolic process	3	21	14.2857142857143	0.0339489182707591	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
down	SCEL; CAMSAP3; STOX2;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.0339489182707591	0.188950981292075	1	1	0.999998327340472	0.999998327340472	1
up	SPI1; RELB; DHRS2; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	7	18	38.8888888888889	0.0345610755002737	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	ADA; ITGA2; TBXA2R; F2R; MYOCD; PROK2; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	7	18	38.8888888888889	0.0345610755002737	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	CLDN1; NOS2; GBP6; CX3CL1; CCL17; CCL19; CCL11;	GO:0071346~cellular response to interferon-gamma	7	96	7.29166666666667	0.0353897015800101	0.194213275511132	1	1	0.999998327340472	0.999998327340472	1
up	CD276; IL27; IL21; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	6	14	42.8571428571429	0.0357408585382211	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	MAP2; CAMSAP3; PARD3; TACC2; TUBB6; TUBAL3; CALML3; CALML5;	GO:0000226~microtubule cytoskeleton organization	8	118	6.77966101694915	0.0361652275405193	0.198125276006207	1	1	0.999998327340472	0.999998327340472	1
down	SRRM4; ESRP1; ESRP2; RBM20;	GO:0043484~regulation of RNA splicing	4	38	10.5263157894737	0.0364288828426907	0.199224392155269	1	1	0.999998327340472	0.999998327340472	1
down	CLEC3B; BMP7; NPPC; STC1; ECM1; ATP6V0A4;	GO:0001503~ossification	6	76	7.89473684210526	0.0365395510311484	0.199484491898895	1	1	0.999998327340472	0.999998327340472	1
down	CIDEA; EDN2; NMU;	GO:0001659~temperature homeostasis	3	22	13.6363636363636	0.0377422942394885	0.204637036176712	1	1	0.999998327340472	0.999998327340472	1
down	TFF1; CYP1A1; LRP11;	GO:0035902~response to immobilization stress	3	22	13.6363636363636	0.0377422942394885	0.204637036176712	1	1	0.999998327340472	0.999998327340472	1
down	GLI2; BMP7; HNF1B;	GO:0048754~branching morphogenesis of an epithelial tube	3	22	13.6363636363636	0.0377422942394885	0.204637036176712	1	1	0.999998327340472	0.999998327340472	1
down	BRINP1; CCL11; PRTG;	GO:0050768~negative regulation of neurogenesis	3	22	13.6363636363636	0.0377422942394885	0.204637036176712	1	1	0.999998327340472	0.999998327340472	1
down	ID1; DLX5; HYAL1; EPGN; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.0380344793631784	0.205868132306519	1	1	0.999998327340472	0.999998327340472	1
down	S100A9; GSTA1; GPX2; GPX3; HBA1; DUOX2;	GO:0098869~cellular oxidant detoxification	6	77	7.79220779220779	0.0384285331366782	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	DHCR24; EGFLAM; BARX2; LAMB4;	GO:0009888~tissue development	4	39	10.2564102564103	0.0392455721962917	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	RAMP3; NFASC; TSPAN15; DPP6; EMP2; WDR72; ABCA12; MRAP2; PKP3;	GO:0072659~protein localization to plasma membrane	9	144	6.25	0.0413909115186425	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	ARHGEF25; EPS8L1; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	3	23	13.0434782608696	0.0417422207494473	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	RHOD; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	3	23	13.0434782608696	0.0417422207494473	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	SCGB1A1; PRLR; STC1; EMP2;	GO:0007566~embryo implantation	4	40	10	0.0421829829294733	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	KRT8; SYNPO2L; MYOZ1; TNNT2;	GO:0045214~sarcomere organization	4	40	10	0.0421829829294733	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	AQP2; ALDH1A3; TDO2; AQP5; MAT1A;	GO:0051289~protein homotetramerization	5	59	8.47457627118644	0.0427154131962403	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
up	OAZ2; SAT1; OAZ1; OAZ3;	GO:0006596~polyamine biosynthetic process	4	7	57.1428571428571	0.0431391985626804	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	TAZ; PGS1; SLC27A1; PTPMT1;	GO:0032049~cardiolipin biosynthetic process	4	7	57.1428571428571	0.0431391985626804	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	LPXN; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0431391985626804	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	CCL21; AXL; CCR7; LILRB1;	GO:2000669~negative regulation of dendritic cell apoptotic process	4	7	57.1428571428571	0.0431391985626804	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	NKX2-8; FGF1; GLI2; PTN; FOXF1; STRA6;	GO:0030324~lung development	6	80	7.5	0.0444632767218083	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	KCNK1; CACNA1G; SLC34A2; SCNN1A; SCNN1B; SCNN1G;	GO:0035725~sodium ion transmembrane transport	6	80	7.5	0.0444632767218083	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	APLNR; SOX18; FOXF1; SOX17; TMEM100;	GO:0001570~vasculogenesis	5	60	8.33333333333333	0.045179965568012	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	BMP2; BMP7; NPPC; FFAR4; NPNT;	GO:0045669~positive regulation of osteoblast differentiation	5	60	8.33333333333333	0.045179965568012	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	PLA2G10; LIPI; PLA2G4D; PLA2G2F;	GO:0006654~phosphatidic acid biosynthetic process	4	41	9.75609756097561	0.0452410749094765	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
up	INHBA; ITGB4; ITGA2; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.0457485703278625	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	TNF; TNFRSF1A; PRKCD; SPHK2; SIRT3;	GO:2000304~positive regulation of ceramide biosynthetic process	5	11	45.4545454545455	0.0457485703278625	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
down	NPPC; EDNRB; AQP1;	GO:0019934~cGMP-mediated signaling	3	24	12.5	0.0459458833899813	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	GLI2; MYO3A; GRHL3;	GO:0090103~cochlea morphogenesis	3	24	12.5	0.0459458833899813	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	LCN2; HYAL1; CCL17; CX3CL1; CCL11; CCL19;	GO:0071347~cellular response to interleukin-1	6	81	7.40740740740741	0.0465987627255151	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	KCNK1; AQP1; KCNJ8; LRRC26; LRRC55; KCNK15; SLC9A2; KCNH5;	GO:0071805~potassium ion transmembrane transport	8	125	6.4	0.0472184707346137	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	WNT9B; TCF21; BMP2; NPNT;	GO:0001658~branching involved in ureteric bud morphogenesis	4	42	9.52380952380952	0.0484196362678456	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	BMP2; BMP7; SERPINB3; BAMBI;	GO:0010718~positive regulation of epithelial to mesenchymal transition	4	42	9.52380952380952	0.0484196362678456	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	CLDN4; PTN; GJB2; DSG1;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.0484196362678456	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	FOXP2; CYP1A1; HES5; STRA6;	GO:0043010~camera-type eye development	4	42	9.52380952380952	0.0484196362678456	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	DKK1; ADH7; LYPD6; DKK4;	GO:2000272~negative regulation of signaling receptor activity	4	42	9.52380952380952	0.0484196362678456	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
down	CHP2; RASAL1; AKR1C3; HPCA; ACER1; SYT8;	GO:0071277~cellular response to calcium ion	6	82	7.31707317073171	0.0487967455840403	0.20740750000523	1	1	0.999998327340472	0.999998327340472	1
up	F2; PRL; TNF; IL5; AKR1B1; IL10; F2R; CRLF3; IL26;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	9	29	31.0344827586207	0.0489321582915944	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
up	F2; C1R; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGHV1-46; IGHV3-13; C4BPA; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; C1S; IGLC2; IGLC3; CD19; IGHV1-2;	GO:0030449~regulation of complement activation	25	113	22.1238938053097	0.0491218165682108	0.981550478108129	1	1	0.999999995615951	0.999999995615951	1
